MarketWatch opinion warns of scams in the coming peptide rush
The column argues consumer demand for wellness peptides is outpacing evidence and oversight, exposing buyers to fraudulent sellers.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 18 07:23 ETSource: MarketWatch
The wire
- 01A MarketWatch opinion piece predicts a wave of consumer fraud as interest in peptides expands beyond prescription channels.
- 02Clinics, telehealth operators and pharmacists face reputational spillover from gray-market sellers marketing research-only compounds to patients.
- 03The piece is commentary rather than reporting on any specific enforcement action or seller.
From the source
Read at marketwatch.comOpinion: More Americans are about to get scammed by the coming peptide rush